Differential expression of transferrin receptor (TfR) in a spectrum of normal to malignant breast tissues: Implications for in situ and invasive carcinoma

Applied Immunohistochemistry and Molecular Morphology

Volumn 19, Issue 5, 2011, Pages 417-423

  Singh, Meenakshi ^a   Mugler, Kimberly ^b   Hailoo, Dulan W ^a   Burke, Stephanie ^a   Nemesure, Barbara ^b   Torkko, Kathleen ^c   Shroyer, Kenneth R ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

ductal carcinoma in situ; immunohistochemistry; invasive breast carcinoma; transferrin receptor

Indexed keywords

CD71 ANTIGEN; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TRANSFERRIN RECEPTOR;

ARTICLE; BREAST CARCINOMA; BREAST EPITHELIUM; BREAST HYPERPLASIA; CARCINOMA IN SITU; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; MEDULLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELLS, CULTURED; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTORS, TRANSFERRIN; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 80052764891     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e318209716e     Document Type: Article

References (22)

1. Schneider C, Owen MJ, Banville D, et al. Primary structure of human transferrin receptor deduced from the mRNA sequence. Nature. 1984;311:675-678. (Pubitemid 14000663)
2. Daniels TR, Delgado T, Rodriguez JA, et al. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol. 2006;121:144-158. (Pubitemid 44592578)
3. Aisen P. Transferrin receptor 1. Int J Biochem Cell Biol. 2004;36: 2137-2143. (Pubitemid 39094437)
4. Gomme PT, McCann KB, Bertolini J. Transferrin: structure, function and potential therapeutic actions. Drug Discov Today. 2005;10:267-273. (Pubitemid 40222220)
5. Hemmaplardh D, Morgan EH. Transferrin and iron uptake by human cells in culture. Exp Cell Res. 1974;87:207-212.
6. Shindelman JE, Ortmeyer AE, Sussman HH. Demonstration of the transferrin receptor in human breast cancer tissue. Potential marker for identifying dividing cells. Int J Cancer. 1981;27: 329-334. (Pubitemid 11155352)
7. Sutherland R, Delia D, Schneider C, et al. Ubiquitous cellsurface glycoprotein on tumor cells is proliferation-associated receptor for transferring. Proc Natl Acad Sci USA. 1981;78: 4515-4519.
8. Trowbridge IS, Omary MB. Human cell surface glycoprotein related to cell proliferation is the receptor for transferring. Proc Natl Acad Sci USA. 1981;78:3039-3043.
9. Gatter KC, Brown G, Trowbridge IS, et al. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J Clin Pathol. 1983;36:539-545. (Pubitemid 13089724)
10. Huebers HA, Finch CA. The physiology of transferrin and transferrin receptors. Physiol Rev. 1987;67:520-582. (Pubitemid 17063609)
11. Larrick JW, Cresswell P. Modulation of cell surface iron transferrin receptors by cellular density and state of activation. J Supramol Struct. 1979;11:579-586. (Pubitemid 10067168)
12. Wrba F, Ritzinger E, Reiner A, et al. Transferrin receptor (TrfR) expression in breast carcinoma and its possible relationship to prognosis. An immunohistochemical study. Virchows Arch A Pathol Anat Histopathol. 1986;410:69-73. (Pubitemid 17011371)
13. Faulk WP, Hsi BL, Stevens PJ. Transferrin and transferrin receptors in carcinoma of the breast. Lancet. 1980;2:390-392. (Pubitemid 10056531)
14. Rosen PP. Apocrine Carcinoma in Rosen's Breast Pathology. 3rd ed. Philadelphis, PA: Wolters Kluwer and Lippincott Williams and Wilkins; 2009:536-550.
15. Walker RA, Day SJ. Transferrin receptor expression in nonmalignant and malignant human breast tissue. J Pathol. 1986;148: 217-224. (Pubitemid 16038737)
16. Singh M, Lu J, Briggs SP, et al. Effect of excess dietary iron on the promotion stage of 1-methyl-1-nitrosourea-induced mammary carcinogenesis: pathogenetic characteristics and distribution of iron. Carcinogenesis. 1994;15:1567-1570. (Pubitemid 24262141)
17. Moore AB, Shannon J, Chen C, et al. Dietary and stored iron as predictors of breast cancer risk: a nested case-control study in shanghai. Int J Cancer. 2009;125:1110-1117.
18. Shpyleva SI, Tryndyak VP, Kovalchuk O, et al. Role of ferritin alterations in human breast cancer cells. Breast Cancer Res Treat.2010. [Epub ahead of print].
19. Daniels TR, Delgado T, Helguera G, et al. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin Immunol. 2006;121:159-176. (Pubitemid 44572972)
20. Li H, Qian ZM. Transferrin/transferrin receptor-mediated drug delivery. Med Res Rev. 2002;22:225-250. (Pubitemid 34415465)
21. Martell LA, Agrawal A, Ross DA, et al. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors. Cancer Res. 1993;53:1348-1353. (Pubitemid 23097115)
22. Food and Drug Administration clears Vermillion's OVA1(TM) Test to determine likelihood of ovarian cancer in women with pelvic mass [Medical News Today web site]. September 12, 2009. Available at: http://www.medicalnewstoday. com/articles/163761.php. [Accessed June 7, 2010].